The Valley Desk

NCT00720499 · Interventional trial

Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Overall registry status Completed

Phase 2

Conditions Pulmonary Disease, Chronic Obstructive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov